MediPharm Labs
(OTC) MEDIF
MediPharm Labs Financials at a Glance
Market Cap
$27.91M
Revenue (TTM)
$45.11M
Net Income (TTM)
$8.27M
EPS (TTM)
$-0.01
P/E Ratio
-4.63
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$0.06
Volume
5,946
Open
$0.06
Price
$0.06
Volume
5,946
Open
$0.06
Previous Close
$0.07
Daily Range
$0.06 - $0.06
52-Week Range
$0.04 - $0.08
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$0.06
Volume
5,946
Open
$0.06
Previous Close
$0.07
Daily Range
$0.06 - $0.06
52-Week Range
$0.04 - $0.08
MEDIF News
3 Pot Stocks to Stay Miles Away From
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MediPharm Labs
Industry
Pharmaceuticals
Sector
Health CareEmployees
127
CEO
David A. Pidduck, EMBA
Website
www.medipharmlabs.comHeadquarters
Barrie, ON L4N 2L1, CA
MEDIF Financials
Key Financial Metrics (TTM)
Gross Margin
31%
Operating Margin
-19%
Net Income Margin
-18%
Return on Equity
-21%
Return on Capital
-23%
Return on Assets
-18%
Earnings Yield
-21.60%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$27.91M
Shares Outstanding
424.86M
Volume
5.95K
Avg. Volume
101.14K
Financials (TTM)
Gross Profit
$13.10M
Operating Income
$8.64M
EBITDA
$6.98M
Operating Cash Flow
$5.33M
Capital Expenditure
$99.92K
Free Cash Flow
$5.43M
Cash & ST Invst.
$10.80M
Total Debt
$200.84K
MediPharm Labs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.05M
-8.2%
Gross Profit
$3.76M
+4.1%
Gross Margin
34.05%
N/A
Market Cap
$27.91M
N/A
Market Cap/Employee
$168.15K
N/A
Employees
166
N/A
Net Income
$1.97M
-13.9%
EBITDA
$1.47M
-28.1%
Quarterly Fundamentals
Net Cash
$10.60M
-7.8%
Accounts Receivable
$7.52M
+0.1%
Inventory
$8.01M
-8.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$200.84K
-40.4%
Return on Assets
-18.07%
N/A
Return on Invested Capital
-23.48%
N/A
Free Cash Flow
$474.61K
+142.7%
Operating Cash Flow
$474.61K
+144.5%